Serum level of follicle-stimulating hormone is associated with extraprostatic extension of prostate cancer
PURPOSE: To determine whether serum follicle-stimulating hormone (FSH) can be used to predict the aggressiveness of prostate cancer prior to radical prostatectomy. METHODS: Ninety-six patients who underwent radical prostatectomy for biopsy proved cT1c-T2N0M0 prostate cancer between 2003 and 2008 wer...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Pacific Prostate Society (APPS)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814124/ https://www.ncbi.nlm.nih.gov/pubmed/24223411 http://dx.doi.org/10.12954/PI.13019 |